UK Facing Higher Medicine Costs And Increased Risk Of Fakes Post-Brexit, European Suppliers Warn0

• BUSINESS
• February 9, 2019

Brexit uncertainty and tighter EU rules could lead to higher medicine prices and a greater risk of fakes entering the UK supply chain, leading European pharmaceutical companies have warned. Complications around the Falsified Medicines Directive (FDM), which comes into force on February 9, is one of many concerns the industry has ahead of the UK’s